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Oral vaccine of Lactococcus lactis harbouring pandemic H1N1 2009 haemagglutinin1 
and nisP anchor fusion protein elevates anti-HA1 sIgA levels in mice 
 
ABSTRACT 
Objective: An oral lactococcal-based vaccine which haboured the haemagglutinin1 (HA1) 
antigen fused to nisP anchor protein for the purpose of surface displaying the HA1 antigen 
was developed against H1N1 virus. Results: Recombinant L. lactis strains expressed HA1-
nisP fusion proteins when induced with nisin, as confirmed through western blotting. 
However, immunofluorescense did not detect any surface-displayed proteins, suggesting that 
the protein was either unsuccessfully translocated or improperly displayed. Despite this, oral 
administration of recombinant L. lactis strains to BALB/c mice revealed that significant 
levels of anti-HA1 sIgA antibodies were detected in mice fecal suspension samples of mice 
group NZ9000 (pNZ:HN) when compared to the negative control NZ9000 (pNZ8048) group. 
Conclusion: Specific anti-HA1 sIgA antibodies were locally produced and live recombinant 
lactococcal vaccine was able to elicit humoral response of BALB/c mice despite unsuccessful 
surface display of the HA1 epitope. 
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